Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI140287-04
National Institutes of Health
Grant: R21AI151363-02
NIAID NIH HHS
Grant: R21 AI151363
NIAID NIH HHS
Grant: R01 AI140287
National Institutes of Health
Grant: 5R21AI151363-02
Use of site-specific pharmacokinetics to optimize antibiotic combinations and prevent the emergence of resistance against CRE
National Institutes of Health
Grant: 5R01AI140287-02
Personalized Antimicrobial Combinations to Combat Resistance
FWCI
1.44
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals